MNR2 Antibody

What is MNR2 and what cellular functions does it serve?

MNR2 (also known as YKL064W) is the fifth yeast CorA homolog identified as being required for magnesium homeostasis. This protein is primarily involved in regulating access to intracellular magnesium stores. Research has shown that MNR2 gene inactivation results in an increase in both magnesium requirement and magnesium content of yeast cells .

The protein was named MNR2 (Manganese Resistance) because deletion mutants show substantial sensitivity to manganese ions and lesser sensitivity to calcium, zinc, and cobalt ions .

How should researchers validate the specificity of MNR2 antibodies?

Methodological approach to antibody validation:

• Genetic validation: Test the antibody against wild-type and mnr2 knockout samples. A specific antibody will show signal in wild-type samples but not in knockouts .

• Multiple assay validation: Following the NeuroMab approach, screen antibodies using at least two different techniques in parallel (e.g., ELISA against recombinant protein and fixed/permeabilized cells expressing MNR2) .

• Cross-reactivity testing: Assess potential cross-reactivity with other CorA family homologs to ensure specificity.

• Epitope mapping: Determine the specific region of MNR2 recognized by the antibody to predict potential cross-reactivity and optimize experimental conditions.

• Peptide competition: Pre-incubate the antibody with the immunizing peptide to confirm epitope specificity.

Multiple validation approaches are crucial as approximately 50% of commercial antibodies fail to meet basic standards for characterization, resulting in billions of dollars in research waste annually .

What essential controls should be included in MNR2 antibody-based experiments?

Methodological control implementation:

Implementing these controls is essential as the antibody characterization crisis has been documented to affect research reproducibility across numerous fields . Following established protocols from initiatives like NeuroMab can help ensure reliable results .

What are the optimal protocols for immunolocalization of MNR2?

Methodological approach for successful immunolocalization:

• Fixation optimization: Since MNR2 is a membrane protein localized to the vacuole, use 4% paraformaldehyde fixation (15-20 minutes) to preserve membrane structures. Test multiple fixation conditions as they can significantly impact epitope accessibility.

• Permeabilization consideration: Use gentle detergents (0.1% Triton X-100 or 0.1% saponin) to allow antibody access while preserving membrane integrity.

• Blocking optimization: Include 5% BSA or normal serum from the secondary antibody species to reduce background. Test multiple blocking conditions if non-specific binding occurs.

• Antibody validation: Following the NeuroMab approach, test multiple antibody clones and concentrations (typically 1-5 μg/ml), as ELISA positivity alone may not predict performance in immunohistochemistry applications .

• Co-localization approach: For definitive localization, perform double labeling with established vacuolar membrane markers.

The NeuroMab initiative emphasizes that protocols successful in one experimental context may not transfer directly to another, highlighting the importance of optimization for each specific research application .

How can researchers address inconsistent results between different MNR2 antibody clones?

Methodological troubleshooting approach:

• Epitope mapping comparison: Determine whether different clones recognize distinct epitopes that might be differentially accessible in various experimental conditions or protein conformations.

• Systematic cross-validation: Test all antibodies under identical conditions with appropriate controls as described in question 1.3. Document performance in a comparison table:

• Orthogonal validation: Confirm results using complementary approaches such as recombinant expression with epitope tags or fluorescent protein fusions.

• Functional context evaluation: Determine if protein interactions, post-translational modifications, or conformational changes affect epitope accessibility in different experimental contexts.

• Transparent reporting: Document antibody performance variations in publications to advance the field's understanding, following principles established by antibody validation initiatives .

What parameters should be optimized for Western blot detection of MNR2?

Methodological optimization strategy:

• Sample preparation:

  • For membrane proteins like MNR2, incorporate membrane fractionation

  • Test multiple lysis buffers containing different detergents (1% digitonin, 0.5% NP-40)

  • Include protease inhibitors to prevent degradation

  • Avoid sample boiling; instead, heat to 37°C for 30 minutes to prevent aggregation

• Gel electrophoresis parameters:

  • Optimize gel percentage (10-12% SDS-PAGE gels typically provide good resolution)

  • Consider gradient gels for better separation

  • Include molecular weight markers and controls as described in question 1.3

• Transfer optimization:

  • Test PVDF versus nitrocellulose membranes (PVDF often works better for hydrophobic proteins)

  • Optimize transfer conditions (voltage/current, duration, buffer composition)

  • Verify transfer efficiency with reversible staining before blocking

• Signal detection parameters:

  • Test multiple blocking agents (milk, BSA, commercial blockers)

  • Titrate antibody concentrations to identify optimal signal-to-noise ratio

  • Compare different detection methods (ECL, fluorescent secondaries)

The importance of optimization is underscored by studies showing that even well-characterized antibodies may require condition adjustment for optimal performance in different applications .

How should researchers interpret unexpected molecular weight bands when using MNR2 antibodies?

Methodological approach to band interpretation:

For accurate interpretation:

• Document molecular weight precisely: Always include calibrated molecular weight markers.

• Compare with literature: Review published studies of MNR2 to identify previously reported band patterns or modifications.

• Apply multiple verification approaches: Confirm band identity using orthogonal methods such as mass spectrometry when possible.

• Consider experimental conditions: Analyze whether buffer components, cell types, or growth conditions affect band patterns.

• Report comprehensively: Document all observations, even those that seem contradictory, to advance collective understanding.

This approach aligns with the antibody characterization issues highlighted in the literature, where proper validation requires multiple complementary approaches .

How can researchers distinguish between specific and non-specific signals in MNR2 localization studies?

Methodological discrimination approach:

• Systematic control analysis: Compare signal patterns between:

  • Wild-type vs. MNR2 knockout samples

  • Primary antibody vs. secondary-only controls

  • Specific antibody vs. isotype controls

  • Pre-immune vs. immune serum (for polyclonal antibodies)

• Signal characteristics evaluation:

  • Specific signal should correspond to known biology (vacuolar membrane localization for MNR2)

  • Signal should be titrable with antibody concentration

  • Signal pattern should be consistent across multiple samples

  • Signal should disappear in competition experiments with immunizing peptide

• Quantitative analysis implementation:

  • Measure signal-to-noise ratios across multiple fields

  • Apply consistent thresholding criteria

  • Use line-scan analysis to confirm membrane localization patterns

  • Apply statistical tests to verify significance of localization patterns

• Orthogonal validation:

  • Confirm localization with multiple antibodies targeting different epitopes

  • Verify with fluorescent protein tagging or alternative approaches

  • Correlate localization with functional assays

This methodological approach follows best practices established by initiatives like NeuroMab, which emphasizes the importance of multiple validation criteria for antibody specificity .

How should conflicting data from different MNR2 antibody-based assays be reconciled?

Methodological reconciliation approach:

• Systematic technical evaluation:

  • Document all experimental variables (antibody clone, lot, concentration, protocol)

  • Test whether discrepancies are reproducible across independent experiments

  • Determine if conflicts are specific to particular experimental conditions

• Epitope accessibility analysis:

  • Map the epitopes recognized by different antibodies

  • Assess whether fixation, extraction, or denaturing conditions affect epitope accessibility

  • Consider whether protein interactions or modifications mask specific epitopes

• Hierarchical validation strategy:

  • Prioritize results from antibodies with the most comprehensive validation

  • Give greater weight to results confirmed by orthogonal, non-antibody methods

  • Consider whether different results might reveal different aspects of protein biology

• Integrative data analysis:

  • Create a comprehensive model incorporating all results

  • Identify conditions under which different results emerge

  • Design experiments specifically to test competing hypotheses

• Transparent reporting:

  • Document all conflicting data in publications

  • Discuss possible explanations for discrepancies

  • Share detailed protocols to enable reproduction by other researchers

This approach addresses the reproducibility challenges in antibody-based research highlighted in the antibody characterization literature, where transparency and multiple validation approaches are essential .

How can MNR2 antibodies be used to study protein-protein interactions in magnesium transport complexes?

Methodological approaches for interaction studies:

• Co-immunoprecipitation optimization:

  • Use chemical crosslinking to stabilize transient interactions

  • Test multiple lysis conditions (detergent types and concentrations)

  • Compare native vs. denaturing/renaturing immunoprecipitation protocols

  • Include appropriate controls (IgG control, knockout samples)

  • Analyze co-precipitated proteins by Western blot or mass spectrometry

• Proximity ligation assay implementation:

  • Combine MNR2 antibody with antibodies against potential partners

  • Visualize protein interactions in situ with subcellular resolution

  • Quantify interaction signals in different cellular compartments

  • Compare interaction patterns under varying magnesium conditions

• FRET/FLIM analysis:

  • Label MNR2 antibodies and partner antibodies with appropriate fluorophore pairs

  • Measure energy transfer as indicator of molecular proximity

  • Analyze interaction dynamics in response to magnesium fluctuations

• Quantitative co-localization:

  • Perform multi-color immunofluorescence with MNR2 and potential partners

  • Apply rigorous co-localization analysis (Pearson's or Manders' coefficients)

  • Use super-resolution microscopy for precise spatial relationships

  • Correlate co-localization with functional magnesium transport assays

These methodologies allow researchers to move beyond simple protein detection to understand the dynamic regulation of magnesium transport complexes within cellular compartments such as the vacuole membrane .

How can researchers study MNR2 conformational changes and their relationship to magnesium transport activity?

Methodological approaches for structure-function analysis:

• Epitope masking analysis:

  • Use a panel of antibodies recognizing different MNR2 epitopes

  • Monitor differential epitope accessibility under varying magnesium concentrations

  • Correlate changes in antibody binding with transport activity

• Limited proteolysis coupled with immunodetection:

  • Expose native MNR2 to limited proteolytic digestion under varying conditions

  • Detect fragments using epitope-specific antibodies

  • Map conformational changes based on differential fragment patterns

• FRET sensors with conformation-specific antibodies:

  • Design antibody-based FRET pairs targeting different regions

  • Monitor FRET changes in response to magnesium levels

  • Correlate FRET signals with transport activity measurements

• Crosslinking mass spectrometry:

  • Apply chemical crosslinkers to capture MNR2 in different conformational states

  • Immunoprecipitate MNR2 complexes

  • Identify crosslinked regions by mass spectrometry

  • Build structural models of different conformational states

• Site-directed mutagenesis with antibody validation:

  • Create mutations in predicted regulatory domains

  • Use antibodies to confirm expression and localization

  • Correlate structural changes with functional outcomes

This approach builds on studies of other CorA family members, where magnesium binding to cytosolic domains alters conformation and regulates transport activity .

How can quantitative imaging approaches with MNR2 antibodies reveal dynamics of magnesium compartmentalization?

Methodological quantitative imaging strategy:

• Correlative fluorescence microscopy:

  • Combine MNR2 immunolabeling with magnesium-sensitive fluorescent probes

  • Analyze spatial relationships between MNR2 localization and magnesium distribution

  • Quantify changes in response to perturbations

• Ratiometric imaging protocol:

  • Normalize MNR2 signal to membrane markers

  • Track relative changes in MNR2 distribution across compartments

  • Apply quantitative image analysis to measure redistribution

• Dynamic imaging implementation:

  • Use minimally disruptive labeling (Fab fragments, nanobodies)

  • Track real-time changes in MNR2 distribution

  • Correlate with magnesium flux using simultaneous magnesium indicators

• Super-resolution microscopy application:

  • Apply STORM, PALM, or STED microscopy for nanoscale resolution

  • Quantify MNR2 clustering and organization in membrane domains

  • Correlate nanoscale organization with transport efficiency

• Computational image analysis:

  • Develop automated segmentation of subcellular compartments

  • Quantify MNR2 density in different membrane regions

  • Apply statistical analysis to identify significant redistribution patterns

This approach aligns with the NeuroMab initiative's emphasis on optimizing methods for specific research applications and developing rigorous quantification approaches .

How can researchers integrate antibody-based MNR2 detection with functional magnesium transport assays?

Methodological integration approach:

• Correlative structure-function analysis:

  • Use antibodies to quantify MNR2 expression levels in different samples

  • Perform parallel magnesium transport assays (uptake/efflux)

  • Establish mathematical relationships between protein levels and transport rates

  • Analyze how mutations or conditions affect this relationship

• Single-cell correlation implementation:

  • Combine immunofluorescence with single-cell magnesium imaging

  • Correlate MNR2 expression/localization with magnesium content at the single-cell level

  • Apply statistical analysis to determine significance of correlations

• Time-resolved correlation:

  • Track changes in MNR2 localization over time after perturbation

  • Simultaneously monitor magnesium redistribution

  • Determine temporal relationships between protein dynamics and ion movement

• Pharmacological manipulation:

  • Use compounds that alter magnesium transport

  • Monitor effects on MNR2 distribution using antibody detection

  • Establish causal relationships between protein dynamics and function

• Genetic complementation analysis:

  • Express wild-type or mutant MNR2 in knockout backgrounds

  • Use antibodies to confirm expression and localization

  • Correlate restoration of localization with functional recovery

This integrative approach enables researchers to move beyond descriptive studies to establish mechanistic understanding of how MNR2 regulates magnesium storage and transport across the vacuolar membrane .

How can MNR2 antibodies be used to investigate the interplay between magnesium homeostasis and stress responses?

Methodological stress-response analysis:

• Stress-induced dynamics tracking:

  • Expose cells to stressors (oxidative stress, metal toxicity, nutrient limitation)

  • Use antibodies to track changes in MNR2 expression and localization

  • Correlate with magnesium redistribution and stress response markers

• Post-translational modification analysis:

  • Develop or acquire modification-specific antibodies (phospho-MNR2, etc.)

  • Monitor modification states under different stress conditions

  • Link specific modifications to changes in transport activity

• Protein interaction network mapping:

  • Perform immunoprecipitation under different stress conditions

  • Identify stress-specific interaction partners

  • Construct dynamic interaction networks that change with cellular state

• Genetic interaction analysis:

  • Combine MNR2 mutation with stress response pathway mutations

  • Use antibodies to track MNR2 in different genetic backgrounds

  • Identify pathway dependencies and regulatory relationships

• Temporal analysis of stress responses:

  • Collect time-course samples after stress induction

  • Track changes in MNR2 status and magnesium distribution

  • Establish sequence of events in stress response pathways

This approach builds on findings that MNR2 mutation affects sensitivity to multiple metal ions, suggesting its role in broader stress response networks beyond simple magnesium transport .

How can researchers use MNR2 antibodies to study evolutionary conservation of magnesium transport mechanisms across species?

Methodological comparative biology approach:

• Cross-species epitope analysis:

  • Test MNR2 antibodies against homologs from different species

  • Map conserved and divergent epitopes

  • Correlate epitope conservation with functional conservation

• Comparative localization studies:

  • Perform immunolocalization in multiple model organisms

  • Compare subcellular distribution patterns

  • Identify conserved and divergent localization mechanisms

• Heterologous expression analysis:

  • Express MNR2 homologs from different species in yeast mutants

  • Use antibodies to confirm expression and localization

  • Correlate with functional complementation

• Domain-specific conservation mapping:

  • Generate antibodies against conserved functional domains

  • Compare accessibility and modification patterns across species

  • Link structural conservation to functional conservation

• Evolutionary rate analysis:

  • Correlate epitope conservation with evolutionary rates

  • Identify rapidly evolving versus conserved regions

  • Use antibodies to probe functional consequences of evolutionary changes

This approach builds on the understanding that MNR2 belongs to the CorA family of magnesium transporters, which has members across prokaryotic and eukaryotic domains of life, with conserved structural features like the cytosolic "funnel" domain that incorporates magnesium-binding regulatory sites .